Could a new drug tame dangerous brain blood vessel clusters?

NCT ID NCT05085561

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This trial tests an experimental drug called REC-994 in adults with symptomatic cerebral cavernous malformation (CCM), a condition where clusters of abnormal blood vessels in the brain can cause bleeding, seizures, and other symptoms. Participants receive either a low or high dose of REC-994 or a placebo for up to a year, with a long-term extension phase. The study measures safety, symptom changes, and bleeding events to see if the drug can help control the disease.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
REC-994
What this could lead to
If successful, REC-994 could become the first drug treatment to reduce symptoms and bleeding events in people with cerebral cavernous malformation.
What could go wrong
This is a small, early-phase trial. The drug may not prove more effective than placebo, and long-term safety is still unknown.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL CAVERNOUS MALFORMATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral cavernous malformation Hemangioma, Cavernous, Central Nervous System

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cleveland Clinic Florida

    Port Saint Lucie, Florida, 34987, United States

  • Columbia University Medical Center

    New York, New York, 10027, United States

  • Emory

    Atlanta, Georgia, 30322, United States

  • Lyerly Neurosurgery

    Jacksonville, Florida, 32207-8202, United States

  • Stanford University

    Palo Alto, California, 94304, United States

  • The University of Texas Southwestern Medical Center

    Dallas, Texas, 75390-8855, United States

  • Thomas Jefferson University

    Philadelphia, Pennsylvania, 19104, United States

  • UCLA

    Los Angeles, California, 90095, United States

  • University of Florida

    Gainesville, Florida, 32608, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15260, United States

  • University of Rochester Medical Center

    Rochester, New York, 14642, United States

  • University of Virginia

    Charlottesville, Virginia, 22908, United States

  • Valley Hospital

    Ridgewood, New Jersey, 07450, United States

  • Xenoscience Inc

    Phoenix, Arizona, 85004, United States